| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| ANVSAnnovis Bio, Inc. | 84.81M | 3.20 | -0.00 | -189.15% | ||||
| CLNNClene Inc. | 60.19M | 5.11 | -0.90 | -47.71% | -142.5% | -17.38% | ||
| ABOSAcumen Pharmaceuticals, Inc. | 112.67M | 1.86 | -1.09 | -143.12% | 0.16 | |||
| BHVNBiohaven Ltd. | 1.58B | 11.92 | -1.28 | -198.83% | 0.09 | |||
| IKTInhibikase Therapeutics, Inc. | 200.09M | 1.65 | -1.42 | -100% | -65.37% | 0.00 | ||
| ALECAlector, Inc. | 198.66M | 1.82 | -1.48 | 3.6% | -156.03% | -186.68% | 0.34 | |
| CGTXCognition Therapeutics, Inc. | 121.82M | 1.38 | -1.62 | -76.61% | 0.04 | |||
| ATHEAlterity Therapeutics Limited | 60M | 3.31 | -2.90 | 35.32% | -330.63% | -73.75% | 0.00 |
| Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 416K | 3.73M | 27.68M | 21.22M | 21.1M | 207.09M | 133.62M | 97.06M | 100.56M |
| Revenue Growth % | - | 7.98% | 6.41% | -0.23% | -0.01% | 8.82% | -0.35% | -0.27% | 0.04% |
| Cost of Goods Sold | 13.67M | 29.91M | 73.03M | 100.53M | 156.87M | 189.41M | 0 | 8.85M | 0 |
| COGS % of Revenue | 32.87% | 8.01% | 2.64% | 4.74% | 7.44% | 0.91% | - | 0.09% | - |
| Gross Profit | -13.26M | -26.18M | -45.35M | -79.31M | -135.77M | 17.68M | 133.62M | 88.21M | 100.56M |
| Gross Margin % | -31.87% | -7.01% | -1.64% | -3.74% | -6.44% | 0.09% | 1% | 0.91% | 1% |
| Gross Profit Growth % | - | -0.97% | -0.73% | -0.75% | -0.71% | 1.13% | 6.56% | -0.34% | 0.14% |
| Operating Expenses | 15.55M | 36.41M | 84.97M | 35.09M | 59.4M | 55.04M | 271.45M | 239.95M | 245.56M |
| OpEx % of Revenue | 37.38% | 9.75% | 3.07% | 1.65% | 2.82% | 0.27% | 2.03% | 2.47% | 2.44% |
| Selling, General & Admin | 1.87M | 6.5M | 11.93M | 33.94M | 59.4M | 55.04M | 61.03M | 56.69M | 59.62M |
| SG&A % of Revenue | 4.5% | 1.74% | 0.43% | 1.6% | 2.82% | 0.27% | 0.46% | 0.58% | 0.59% |
| Research & Development | 13.67M | 29.91M | 73.03M | 100.53M | 156.87M | 189.41M | 210.42M | 192.12M | 185.94M |
| R&D % of Revenue | 32.87% | 8.01% | 2.64% | 4.74% | 7.44% | 0.91% | 1.57% | 1.98% | 1.85% |
| Other Operating Expenses | 22K | 199K | 5.04M | -99.37M | -156.87M | -189.41M | 0 | -8.85M | 0 |
| Operating Income | -15.13M | -32.68M | -57.29M | -114.4M | -195.17M | -37.36M | -137.83M | -151.74M | -145M |
| Operating Margin % | -36.38% | -8.75% | -2.07% | -5.39% | -9.25% | -0.18% | -1.03% | -1.56% | -1.44% |
| Operating Income Growth % | - | -1.16% | -0.75% | -1% | -0.71% | 0.81% | -2.69% | -0.1% | 0.04% |
| EBITDA | -14.93M | -32M | -56.27M | -110.63M | -187.91M | -29.05M | -129.36M | -142.89M | -136.16M |
| EBITDA Margin % | -35.89% | -8.57% | -2.03% | -5.21% | -8.91% | -0.14% | -0.97% | -1.47% | -1.35% |
| EBITDA Growth % | - | -1.14% | -0.76% | -0.97% | -0.7% | 0.85% | -3.45% | -0.1% | 0.05% |
| D&A (Non-Cash Add-back) | 201K | 680K | 1.02M | 3.77M | 7.26M | 8.31M | 8.47M | 8.85M | 8.84M |
| EBIT | -15.13M | -32.68M | -57.29M | -113.25M | -195.17M | -37.36M | -137.83M | -151.74M | -145M |
| Net Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 22K | 199K | 5.04M | 9.02M | 4.95M | 1.03M | 7.78M | 26.56M | 26.08M |
| Pretax Income | -15.11M | -32.48M | -52.25M | -105.39M | -190.23M | -36.33M | -130.06M | -125.18M | -118.92M |
| Pretax Margin % | -36.32% | -8.7% | -1.89% | -4.97% | -9.02% | -0.18% | -0.97% | -1.29% | -1.18% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 3.25M | 5.21M | 128K |
| Effective Tax Rate % | 1% | 1% | 1% | 1% | 1% | 1% | 1.03% | 1.04% | 1% |
| Net Income | -15.11M | -32.48M | -52.25M | -105.39M | -190.23M | -36.33M | -133.31M | -130.39M | -119.05M |
| Net Margin % | -36.32% | -8.7% | -1.89% | -4.97% | -9.02% | -0.18% | -1% | -1.34% | -1.18% |
| Net Income Growth % | - | -1.15% | -0.61% | -1.02% | -0.81% | 0.81% | -2.67% | 0.02% | 0.09% |
| Net Income (Continuing) | -15.11M | -32.48M | -52.25M | -105.39M | -190.23M | -36.33M | -133.31M | -130.39M | -119.05M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.78 | -0.63 | -0.76 | -1.62 | -2.45 | -0.45 | -1.62 | -1.56 | -1.23 |
| EPS Growth % | - | 0.65% | -0.21% | -1.13% | -0.51% | 0.82% | -2.6% | 0.04% | 0.21% |
| EPS (Basic) | -1.78 | -0.63 | -0.76 | -1.62 | -2.45 | -0.45 | -1.62 | -1.56 | -1.23 |
| Diluted Shares Outstanding | 8.5M | 51.22M | 68.37M | 61.73M | 77.76M | 80.42M | 82.47M | 83.73M | 96.59M |
| Basic Shares Outstanding | 8.5M | 51.22M | 68.37M | 61.73M | 77.76M | 80.42M | 82.47M | 83.73M | 96.59M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - |
| Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 51.19M | 232.97M | 293.18M | 357.44M | 421.51M | 749.71M | 726.43M | 565.81M | 424.82M |
| Cash & Short-Term Investments | 50.84M | 32.45M | 290.41M | 353.07M | 413.31M | 735.25M | 712.85M | 548.86M | 413.4M |
| Cash Only | 50.84M | 32.45M | 65.47M | 89.64M | 49.97M | 329.15M | 154.32M | 74.56M | 33.02M |
| Short-Term Investments | 0 | 0 | 224.94M | 263.43M | 363.34M | 406.1M | 558.53M | 474.31M | 380.38M |
| Accounts Receivable | 218K | 200.24M | 0 | 0 | 0 | 7.39M | 2.59M | 0 | 0 |
| Days Sales Outstanding | 191.27 | 19.57K | - | - | - | 13.03 | 7.07 | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 0 | 2.77M | 0 | 0 | 0 | 0 | 16.95M | 11.42M |
| Total Non-Current Assets | 2.92M | 3.09M | 15.18M | 64.48M | 66.74M | 64.94M | 61.21M | 56.02M | 43.49M |
| Property, Plant & Equipment | 2.54M | 2.83M | 10.94M | 62.33M | 62.65M | 57.9M | 53.33M | 47.06M | 37.1M |
| Fixed Asset Turnover | 0.16x | 1.32x | 2.53x | 0.34x | 0.34x | 3.58x | 2.51x | 2.06x | 2.71x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 200K | 0 | 1.47M | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 184K | 252K | 2.77M | 2.15M | 4.09M | 7.05M | 7.88M | 8.96M | 6.39M |
| Total Assets | 54.11M | 236.06M | 308.36M | 421.91M | 488.25M | 814.66M | 787.65M | 621.83M | 468.3M |
| Asset Turnover | 0.01x | 0.02x | 0.09x | 0.05x | 0.04x | 0.25x | 0.17x | 0.16x | 0.21x |
| Asset Growth % | - | 3.36% | 0.31% | 0.37% | 0.16% | 0.67% | -0.03% | -0.21% | -0.25% |
| Total Current Liabilities | 1.51M | 27.4M | 13.04M | 61.97M | 68.09M | 139.56M | 93.81M | 177.95M | 125.06M |
| Accounts Payable | 1.15M | 1.14M | 126K | 278K | 3M | 4.75M | 4.19M | 3.77M | 2.21M |
| Days Payables Outstanding | 30.75 | 13.91 | 0.63 | 1.01 | 6.99 | 9.15 | - | 155.73 | - |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Liabilities | 0 | 5.6M | 9.56M | 5.73M | 7.29M | 11.66M | 12.76M | 54.74M | 54.55M |
| Current Ratio | 33.90x | 8.50x | 22.48x | 5.77x | 6.19x | 5.37x | 7.74x | 3.18x | 3.40x |
| Quick Ratio | 33.90x | 8.50x | 22.48x | 5.77x | 6.19x | 5.37x | 7.74x | 3.18x | 3.40x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 77.51M | 260.69M | 392.71M | 165.2M | 152.63M | 374.38M | 479.4M | 309.72M | 216.44M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9.39M |
| Capital Lease Obligations | 0 | 0 | 0 | 41.47M | 43.74M | 39.81M | 35.27M | 30.46M | 24.38M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 77.51M | 77.54M | 7.57M | 493K | 472K | 158K | 759K | 68.42M | 10.51M |
| Total Liabilities | 79.02M | 288.09M | 405.76M | 227.17M | 220.72M | 513.93M | 573.21M | 487.67M | 341.5M |
| Total Debt | 0 | 0 | 0 | 48.04M | 51.26M | 47.6M | 43.33M | 38.92M | 42.52M |
| Net Debt | -50.84M | -32.45M | -65.47M | -41.6M | 1.29M | -281.55M | -111M | -35.64M | 9.5M |
| Debt / Equity | - | - | - | 0.25x | 0.19x | 0.16x | 0.20x | 0.29x | 0.34x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - |
| Total Equity | -24.91M | -52.03M | -97.4M | 194.74M | 267.53M | 300.72M | 214.44M | 134.16M | 126.8M |
| Equity Growth % | - | -1.09% | -0.87% | 3% | 0.37% | 0.12% | -0.29% | -0.37% | -0.05% |
| Book Value per Share | -2.93 | -1.02 | -1.42 | 3.15 | 3.44 | 3.74 | 2.60 | 1.60 | 1.31 |
| Total Shareholders' Equity | -24.91M | -52.03M | -97.4M | 194.74M | 267.53M | 300.72M | 214.44M | 134.16M | 126.8M |
| Common Stock | 0 | 1K | 1K | 7K | 8K | 8K | 8K | 8K | 9K |
| Retained Earnings | -29.71M | -62.19M | -114.44M | -219.82M | -410.05M | -446.38M | -579.69M | -710.08M | -829.13M |
| Treasury Stock | 0 | 0 | 193.44M | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -300K | -980K | -42K | 142K | 614K | -943K | -4.58M | 184K | 261K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -12.99M | -17.77M | 127.46M | -99.31M | -166.73M | 298.55M | -20.33M | -184.16M | -229.91M |
| Operating CF Margin % | -31.23% | -4.76% | 4.61% | -4.68% | -7.9% | 1.44% | -0.15% | -1.9% | -2.29% |
| Operating CF Growth % | - | -0.37% | 8.17% | -1.78% | -0.68% | 2.79% | -1.07% | -8.06% | -0.25% |
| Net Income | -15.11M | -32.48M | -52.25M | -105.39M | -190.23M | -36.33M | -133.31M | -130.39M | -119.05M |
| Depreciation & Amortization | 201K | 680K | 1.02M | 5.57M | 7.26M | 8.31M | 8.47M | 8.85M | 8.84M |
| Stock-Based Compensation | 1.96M | 5.35M | 6.92M | 0 | 30.52M | 40.78M | 0 | 42.8M | 39.46M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 1.88M | 6.78M | -2.59M | 12.78M | 929K | 2.1M | 44.98M | -15.27M | -12.17M |
| Working Capital Changes | -47K | 8.68M | 174.36M | -12.27M | -15.22M | 283.68M | 59.53M | -90.15M | -146.99M |
| Change in Receivables | -218K | -20K | 238K | 0 | 0 | -7.39M | 4.8M | 2.59M | 0 |
| Change in Inventory | -560K | 6.58M | 2.45M | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 708K | -41K | -809K | 152K | 2.41M | 1.92M | -572K | -377K | -1.44M |
| Cash from Investing | -2.25M | -801K | -224.12M | -48.87M | -105.05M | -49.66M | -159.01M | 101.92M | 107.13M |
| Capital Expenditures | -2.25M | -801K | -1.88M | -15.27M | -5.03M | -3.25M | -4.12M | -2.38M | -1.25M |
| CapEx % of Revenue | 5.41% | 0.21% | 0.07% | 0.72% | 0.24% | 0.02% | 0.03% | 0.02% | 0.01% |
| Acquisitions | - | - | - | - | - | - | - | - | - |
| Investments | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | -222.24M | 0 | -100.02M | 0 | 0 | 0 | 0 |
| Cash from Financing | -77K | -15K | 131.15M | 172.35M | 232.11M | 30.3M | 4.51M | 2.55M | 81.54M |
| Debt Issued (Net) | - | - | - | - | - | - | - | - | - |
| Equity Issued (Net) | - | - | - | - | - | - | - | - | - |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | - | - | - | - | - | - | - | - | - |
| Other Financing | -77K | -15K | 131.15M | 0 | 7.51M | 30.3M | 0 | 0 | 1.04M |
| Net Change in Cash | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | -15.24M | -18.57M | 125.58M | -114.57M | -171.77M | 295.3M | -24.45M | -186.54M | -231.16M |
| FCF Margin % | -36.64% | -4.97% | 4.54% | -5.4% | -8.14% | 1.43% | -0.18% | -1.92% | -2.3% |
| FCF Growth % | - | -0.22% | 7.76% | -1.91% | -0.5% | 2.72% | -1.08% | -6.63% | -0.24% |
| FCF per Share | -1.79 | -0.36 | 1.84 | -1.86 | -2.21 | 3.67 | -0.30 | -2.23 | -2.39 |
| FCF Conversion (FCF/Net Income) | 0.86x | 0.55x | -2.44x | 0.94x | 0.88x | -8.22x | 0.15x | 1.41x | 1.93x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | - | -216.52% | -82.3% | -12.79% | -51.75% | -74.81% | -91.24% |
| Return on Invested Capital (ROIC) | - | - | - | - | -69.38% | -19.46% | -168.61% | -112.7% | -92.62% |
| Gross Margin | -3187.02% | -700.83% | -163.87% | -373.76% | -643.53% | 8.54% | 100% | 90.88% | 100% |
| Net Margin | -3632.21% | -869.61% | -188.78% | -496.65% | -901.64% | -17.54% | -99.77% | -134.34% | -118.39% |
| Debt / Equity | - | - | - | 0.25x | 0.19x | 0.16x | 0.20x | 0.29x | 0.34x |
| FCF Conversion | 0.86x | 0.55x | -2.44x | 0.94x | 0.88x | -8.22x | 0.15x | 1.41x | 1.93x |
| Revenue Growth | - | 797.84% | 641.02% | -23.33% | -0.57% | 881.54% | -35.48% | -27.36% | 3.6% |
| 2021 | |
|---|---|
| Phase Three License | 173.4M |
| Phase Three License Growth | - |
Alector, Inc. (ALEC) reported $69.0M in revenue for fiscal year 2024. This represents a 16498% increase from $0.4M in 2016.
Alector, Inc. (ALEC) grew revenue by 3.6% over the past year. Growth has been modest.
Alector, Inc. (ALEC) reported a net loss of $107.7M for fiscal year 2024.
Alector, Inc. (ALEC) has a return on equity (ROE) of -91.2%. Negative ROE indicates the company is unprofitable.
Alector, Inc. (ALEC) had negative free cash flow of $197.6M in fiscal year 2024, likely due to heavy capital investments.